Juan Francisco
Navarro González
External Researcher
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublications in collaboration with researchers from Hospital Clinico Universitario de Valencia (18)
2024
-
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
Nefrologia , Vol. 44, Núm. 2, pp. 241-250
-
Risk factors for progression in KDOQI stage 3 Chronic Kidney Disease (PROGRESER study)
Nefrologia, Vol. 44, Núm. 5, pp. 689-699
2023
-
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597
-
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study
Frontiers in Cardiovascular Medicine, Vol. 10
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
Nefrologia, Vol. 42, Núm. 6, pp. 645-655
2021
-
Optimizing the timing of nephrology referral for patients with diabetic kidney disease
Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8
-
Setting up a cardiorenal clinic. Consensus document of the cardiorenal working groups of the Spanish Society of Cardiology and the Spanish Society of Nephrology
REC: CardioClinics, Vol. 56, Núm. 4, pp. 284-295
-
Urinary Dickkopf-3: A new biomarker for CKD progression and mortality
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2199-2207
2020
-
GLP-1 receptor agonists and diabetic kidney disease: A call of attention to nephrologists
Journal of Clinical Medicine, Vol. 9, Núm. 4
-
Prevalence of vertebral fractures and their prognostic significance in the survival in patients with chronic kidney disease stages 3-5 not on dialysis
Journal of Clinical Medicine, Vol. 9, Núm. 5, pp. 1-11
-
SGLT2 inhibitors for non-diabetic kidney disease: Drugs to treat CKD that also improve glycaemia
Clinical Kidney Journal, Vol. 13, Núm. 5, pp. 728-733
2019
-
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 313-321
-
Will the new hypoglycaemic agents be effective on renal and cardiovascular protection in diabetes and renal diabetic disease?
Nefrologia, Vol. 39, Núm. 1, pp. 3-10
-
¿Serán las nuevas moléculas efectivas en protección renal y cardiovascular en la diabetes mellitus y la enfermedad renal diabética?
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
2018
-
Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease
Diabetes Care, Vol. 41, Núm. 8, pp. 1817-1820
2017
-
ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
Nefrologia, Vol. 37, Núm. 6, pp. 567-571